Medicare:
Alternatives for Computing Payments for Hospital Outpatient Surgery
HRD-90-78: Published: Apr 3, 1990. Publicly Released: Apr 3, 1990.
Additional Materials:
- Full Report:
Contact:
(202) 512-7119
contact@gao.gov
Office of Public Affairs
(202) 512-4800
youngc1@gao.gov
Pursuant to a congressional request, GAO reviewed three alternatives to the current Medicare payment methodology for hospital outpatient surgery.
GAO found that Medicare's: (1) hospital payment system had problems in computing and applying beneficiary coinsurance amounts; and (2) outpatient payment computation method did not take full advantage of beneficiary coinsurance amounts to reduce its payments. GAO also found that: (1) under one alternative, billed charges would be converted to Medicare-allowable costs by using the hospital's cost-to-charge ratio combined with ambulatory surgery center payment amounts; (2) another alternative would base beneficiary coinsurance on Medicare-allowable costs, rather than on hospital-submitted charges; and (3) another alternative would make the beneficiary coinsurance payment exactly 20 percent of the Medicare blended amount. GAO also noted that: (1) the third alternative would result in the greatest beneficiary liability reduction with the highest Medicare payment and would require the implementation of a prospective payment system; (2) the second alternative would split the reduction in the hospital payment between the Medicare program and the beneficiary; and (3) the first alternative would result in no beneficiary relief.
Matter for Congressional Consideration
Status: Closed - Not Implemented
Comments: Congress elected not to revise the current payment system but to move toward a prospective payment system for hospital outpatient surgery.
Matter: Because it may be some time before a prospective payment system for hospital outpatient surgery is designed and implemented, Congress should consider an interim solution to the shortcomings of the current payment methodology. Depending on the policy objectives to be satisfied, either the first or second alternative presented in this report would be suitable.
Explore the full database of GAO's Open Recommendations
»
Mar 3, 2021
-
Drug Safety:
FDA's Future Inspection Plans Need to Address Issues Presented by COVID-19 BacklogGAO-21-409T: Published: Mar 4, 2021. Publicly Released: Mar 3, 2021.
Mar 1, 2021
-
Medicare Part B:
Payments and Use for Selected New, High-Cost DrugsGAO-21-252: Published: Mar 1, 2021. Publicly Released: Mar 1, 2021.
Feb 24, 2021
-
Covid-19:
Key Insights from GAO's Oversight of the Federal Public Health ResponseGAO-21-396T: Published: Feb 24, 2021. Publicly Released: Feb 24, 2021.
Feb 17, 2021
Feb 11, 2021
-
Operation Warp Speed:
Accelerated COVID-19 Vaccine Development Status and Efforts to Address Manufacturing ChallengesGAO-21-319: Published: Feb 11, 2021. Publicly Released: Feb 11, 2021.
Feb 5, 2021
-
DOD Health Care:
DOD Should Monitor Implementation of Its Clinical Practice GuidelinesGAO-21-237: Published: Feb 5, 2021. Publicly Released: Feb 5, 2021. -
Medicaid:
CMS Needs to Implement Risk-Based Oversight of Puerto Rico's Procurement ProcessGAO-21-229: Published: Feb 5, 2021. Publicly Released: Feb 5, 2021. -
VA Health Care:
Community Living Centers Were Commonly Cited for Infection Control Deficiencies Prior to the COVID-19 PandemicGAO-21-195R: Published: Jan 6, 2021. Publicly Released: Feb 5, 2021.
Jan 28, 2021
-
COVID-19:
Critical Vaccine Distribution, Supply Chain, Program Integrity, and Other Challenges Require Focused Federal AttentionGAO-21-265: Published: Jan 28, 2021. Publicly Released: Jan 28, 2021.
Jan 21, 2021
-
Rural Hospital Closures:
Affected Residents Had Reduced Access to Health Care ServicesGAO-21-93: Published: Dec 22, 2020. Publicly Released: Jan 21, 2021.
Looking for more? Browse all our products here